Turn a new leaf in 2020 by updating your routine clinical counselling of men with non-metastatic #ProstateCancer: increase confidence in decision making, reduce over treatment, provide personalized prognostic data & help your patients live a quality life. #HappyNewYear
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment https://t.co/UbMxA8j1U2 Long term side effects comparison now included in Predict Prostate - toggle impact at 3/6/9/12 years for different treatments 👉🏾https://t.co/cTl7B72BUS @ProstateUK@CRUK_Policy
Online and #OpenAccess: Utilisation and impact of "Predict Prostate" on decision-making among clinicians and patients in a specialist tertiary referral centre: A retrospective cohort study by @lambwben et al
https://t.co/Mj6hd0KHC2
The Predict:Prostate tool (https://t.co/dzgVE4Keq2) is now updated with new data on the possible harms of the different treatment options. You can now select how many years ahead you want to look. You can weigh these against the possible survival benefit that the site calculates.
Predict Prostate ora lanciato in lingua italiana: dai un'occhiata! Predict Prostate is now available in Italian - Thank you! @AlbertoCoscione@luca_orecchia@robymiano
How can men with #prostatecancer and their clinicians be supported to properly assess the risks and benefits of #activesurveillance? Europa Uomo’s latest AS webinar will focus on the Predict decision-making tool developed by @VincentGnanapr3@CRUK_CI See https://t.co/2SLV2fqIpI
@NICEComms endorsed Predict Prostate on @CR_UK and @macmillancancer prostate cancer for patients information pages - we hope it helps men get a unbiased idea of the prognosis from a new diagnosis of early cancer
Use of MRI based vs clinical diagnostic data in calculating https://t.co/O3e0Uj1iCO OS benefits from treatment vs conservative management 👉 https://t.co/P1mw9ohJT4
Predict Prostate now updated with 6 year functional outcomes from the Protect study 👉check it out https://t.co/O3e0Uj1iCO + our 4 new language versions
Predict Prostate now updated with 6 year functional outcomes from the Protect study 👉check it out https://t.co/O3e0Uj1iCO + our 4 new language versions
We agree with @AmerUrological 2022 guideline on how to handle MRI target & systematic biopsy in risk estimation in #prostatecancer - avoids grade inflation and risk over-estimation 👉see how this works in practice https://t.co/O3e0Uj1iCO
A lot of hard work here from Gabe and the team to produce better genetic test reports, which patients (and clinicians!) understand and find helpful.
The problem now - getting them into actual use in the medical system! Please RT to spread the word to someone who can get them used
Predict:Prostate Cancer (https://t.co/16F6OfW7sj) is now available in French, German, Portuguese and Simplified Chinese. Thank you to our volunteer translators. We hope this brings good information to more people making difficult treatment decisions. @d_spiegel@paulpharoah
Nice paper: Variation in Communication of Competing Risks of Mortality in Prostate Cancer Consultations “trifecta” approach(1)probability of cancer mortality(2)with/without treatment (3)patient LE".
exactly what @PredictProstate does- check it out
https://t.co/ubXXymxlOi
>29,000 uses of @PredictProstate in the past 12 months alone 🙌. Working on German, Mandarin and French translation of the site, Portuguese soon - looking for Italian, Spanish colleagues interested to help with translation DM or email at [email protected]
I find this tool really helpful as men often overestimate the risk of Prostate cancer death and the potential benefit of treatment and under estimate their (often much larger) risk of death from other causes.